熔点	262-264 ºC

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?Tanya Siddiqi et al.Hematology. American Society of Hematology. Education Program, 2012, 246-250 (2012-12-13) Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab.A M Fink et al.Leukemia, 27(9), 1949-1952 (2013-06-22) Successful allogeneic hemopoietic stem cell transplantation in a case of Wiskott-Aldrich syndrome and non-Hodgkin lymphoma.Betul Tavil et al.Pediatric transplantation, 17(6), E146-E148 (2013-06-19) Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximabZent CS, et al. Leukemia Research, 32(12), 1849-1856 (2008) R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.Massimo Federico et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1506-1513 (2013-03-27) Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.Jorge E Cortes et al.Cancer, 121(2), 234-242 (2014-09-17) Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria.Michael P B Sandrini et al.Antimicrobial agents and chemotherapy, 51(8), 2726-2732 (2007-05-29) Dasatinib in combination with fludarabine in patients with refractory chronic lymphocytic leukemia: a multicenter phase 2 study.Arnon P Kater et al.Leukemia research, 38(1), 34-41 (2013-11-19) Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein.N Purroy et al.Leukemia, 28(10), 1993-2004 (2014-03-13) Bendamustine compared to fludarabine as second-line treatment in chronic lymphocytic leukemia.Norbert Niederle et al.Annals of hematology, 92(5), 653-660 (2013-01-24) Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.Li Gao et al.Leukemia research, 37(11), 1482-1487 (2013-09-24) The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL cells in vitro, as a single agent and in combination with other drugs.Aneel Paulus et al.British journal of haematology, 165(1), 78-88 (2014-01-29) Chronic lymphocytic leukemia in a child: a challenging diagnosis in pediatric oncology practice.Hacı Ahmet Demir et al.Pediatric blood & cancer, 61(5), 933-935 (2013-11-20) Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.Jennifer A Woyach et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(4), 440-447 (2012-12-13) Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.Gautam Borthakur et al.American journal of hematology, 89(10), 964-968 (2014-07-06) Richter syndrome: chronic lymphocytic leukemia transformation into Hodgkin's disease.Ofir Zavdy et al.The Israel Medical Association journal : IMAJ, 15(10), 650-651 (2013-11-26) Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG.Hawk Kim et al.Leukemia research, 38(7), 730-736 (2014-05-21) Fludarabine Inhibits KAlicia de la Cruz et al.Frontiers in pharmacology, 8, 177-177 (2017-04-15) Thrombotic microangiopathy in metastatic melanoma patients treated with adoptive cell therapy and total body irradiation.Jennifer Tseng et al.Cancer, 120(9), 1426-1432 (2014-01-30) Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia.Marta Krejci et al.Annals of hematology, 92(10), 1397-1403 (2013-06-04) Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.Enrico De Astis et al.Annals of hematology, 93(12), 2011-2018 (2014-07-06) Reevaluation of ATR signaling in primary resting chronic lymphocytic leukemia cells: evidence for pro-survival or pro-apoptotic function.Maxime Beyaert et al.Oncotarget, 8(34), 56906-56920 (2017-09-17) Interactions between 2-fluoroadenine 9-beta-d-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cellsHarvey S, et al. Clinical Cancer Research, 7(2), 320-330 (2001) Release of an ~55kDa fragment containing the actin-binding domain of β-spectrin by caspase-8 during FND-induced apoptosis depends on the presence of protein 4.1.Monika Toporkiewicz et al.Archives of biochemistry and biophysics, 535(2), 205-213 (2013-04-13) Effect of IFN-α on KC and LIX expression: role of STAT1 and its effect on neutrophil recruitment to the spleen after lipopolysaccharide stimulation.Huayang Pan et al.Molecular immunology, 56(1-2), 12-22 (2013-05-07) [Subcutaneous panniculitis-like T-cell lymphoma following treatment with rituximab and cyclophosphamide].J-L Schmutz et al.Annales de dermatologie et de venereologie, 140(3), 246-247 (2013-03-08) Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.Pau Abrisqueta et al.Blood, 122(24), 3951-3959 (2013-10-15) IgG4-related disease with hypergammaglobulinemic hyperviscosity and retinopathy.Patrick C W Wong et al.European journal of haematology, 90(3), 250-256 (2013-01-03) A novel bioluminescent bacterial biosensor for measurement of Ara-CTP and cytarabine potentiation by fludarabine in seven leukaemic cell lines.Elizabeth Anderson et al.Leukemia research, 37(6), 690-696 (2013-03-12) CX-4945, a selective inhibitor of casein kinase-2 (CK2), exhibits anti-tumor activity in hematologic malignancies including enhanced activity in chronic lymphocytic leukemia when combined with fludarabine and inhibitors of the B-cell receptor pathway.R C Prins et al.Leukemia, 27(10), 2094-2096 (2013-08-01) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.M J Keating et al.Blood, 74(1), 19-25 (1989-07-01) Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity.Lucie Brulíková et al.European journal of medicinal chemistry, 45(9), 3588-3594 (2010-07-08) Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.Sanne H Tonino et al.Leukemia & lymphoma, 56(8), 2439-2447 (2014-12-17) Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.Deepa Jayakody Arachchillage et al.British journal of haematology, 166(1), 142-145 (2014-03-19) Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantation.Su-Peng Yeh et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(5), 1199-1206 (2013-12-10) Cyclophosphamide for CLL: to be or not CYP2B activated?Christian H Geisler Blood, 122(26), 4156-4157 (2013-12-21) Fludarabine, cytarabine, granulocyte colony-stimulating factor and melphalan (FALG with L-PAM) as a reduced toxicity conditioning regimen in children with acute leukemia.Koji Kato et al.Pediatric blood & cancer, 61(4), 712-716 (2014-01-01) Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.Ayad Ahmed Hussein et al.Pediatric blood & cancer, 60(8), 1345-1349 (2013-02-21) CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia.Gillian G Johnson et al.Blood, 122(26), 4253-4258 (2013-10-17) Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.M J Keating et al.Blood, 74(1), 19-25 (1989-07-01) Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.Sanne H Tonino et al.Leukemia & lymphoma, 56(8), 2439-2447 (2014-12-17) Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.Hui Liu et al.Journal of hematology & oncology, 6, 15-15 (2013-02-12) Synthesis of 5-[alkoxy-(4-nitro-phenyl)-methyl]-uridines and study of their cytotoxic activity.Lucie Brulíková et al.European journal of medicinal chemistry, 45(9), 3588-3594 (2010-07-08) Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia.Paolo Strati et al.Cancer, 119(21), 3805-3811 (2013-08-15) The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab.Anna Panovská et al.European journal of haematology, 90(6), 479-485 (2013-03-20) Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation.Petra Langerbeins et al.American journal of hematology, 89(12), E239-E243 (2014-09-10) De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".Marino Clavio et al.Annals of hematology, 92(10), 1309-1318 (2013-05-21) Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.Ji Hyun Kim et al.International journal of radiation oncology, biology, physics, 89(1), 75-81 (2014-04-15) Synthesis and evaluation of the substrate activity of C-6 substituted purine ribosides with E. coli purine nucleoside phosphorylase: palladium mediated cross-coupling of organozinc halides with 6-chloropurine nucleosides.Abdalla E A Hassan et al.European journal of medicinal chemistry, 47(1), 167-174 (2011-11-25) Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.Laura De Padua et al.Annals of hematology, 93(7), 1261-1262 (2013-12-07) Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies.Karl R VanDerMeid et al.Cancer immunology research, 6(10), 1150-1160 (2018-08-10) Busulfan, fludarabine, and alemtuzumab conditioning and unrelated cord blood transplantation in children with sickle cell disease.Kavita Radhakrishnan et al.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19(4), 676-677 (2013-02-14) Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.Karin Garming Legert et al.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 22(8), 2133-2140 (2014-03-22) Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.Marc Castellví et al.Cancers, 12(3) (2020-03-22) Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.Wolfgang Dörffel et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1562-1568 (2013-03-20) Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study.Tayfun Güngör et al.Lancet (London, England), 383(9915), 436-448 (2013-10-29) Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignancies.Pere Barba et al.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19(4), 597-601 (2013-01-12) Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.Francesco Ceppi et al.Journal of pediatric hematology/oncology, 36(5), e319-e321 (2014-07-01) Retrospective comparison of fludarabine in combination with intermediate-dose cytarabine versus high-dose cytarabine as consolidation therapies for acute myeloid leukemia.Wenjun Zhang et al.Medicine, 93(27), e134-e134 (2014-12-17) Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.Véronique Leblond et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(3), 301-307 (2012-12-13) Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.Georg Hopfinger et al.Cancer, 119(12), 2258-2267 (2013-03-21) HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine.Lina Benajiba et al.Blood, 125(2), 417-418 (2015-01-13) The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms.Talia Diker-Cohen et al.Leukemia & lymphoma, 54(9), 2023-2029 (2012-12-18) Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia.Alessandro Gozzetti et al.Leukemia research, 38(8), 891-895 (2014-06-18) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.Lourdes Santana et al.Journal of medicinal chemistry, 51(21), 6740-6751 (2008-10-07) Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells.Jakub Bogusz et al.Postepy higieny i medycyny doswiadczalnej (Online), 67, 107-118 (2013-03-12) Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotideEissner G, et al. Blood, 100(1), 334-340 (2002) Reduced drug incorporation into DNA and antiapoptosis as the crucial mechanisms of resistance in a novel nelarabine-resistant cell line.Takahiro Yamauchi et al.BMC cancer, 14, 547-547 (2014-07-30) Indole-3-Carbinol Synergizes with and Restores Fludarabine Sensitivity in Chronic Lymphocytic Leukemia Cells Irrespective of p53 Activity and Treatment Resistances.Gema Perez-Chacon et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 22(1), 134-145 (2015-09-02) Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.Dario Ferrero et al.Annals of hematology, 93(8), 1391-1400 (2014-04-08) HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia.Valentina Griggio et al.Haematologica, 105(4), 1042-1054 (2019-07-11) Conditioning with purine analogs leads to good engraftment rates of immunodepleted grafts for aplastic anemia.Nicolas Novitzky et al.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 19(4), 584-588 (2012-12-29) Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia.Muhammad Rizwan Khawaja et al.American journal of hematology, 90(2), 97-99 (2014-10-28) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.R Scott Obach et al.Drug metabolism and disposition: the biological fate of chemicals, 36(7), 1385-1405 (2008-04-23) Activation of the STAT1 Pathway Accelerates Periodontitis in Nos3-/- Mice.W Wei et al.Journal of dental research, 98(9), 1027-1036 (2019-07-23) QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.Andrey A Toropov et al.European journal of medicinal chemistry, 45(4), 1639-1647 (2010-01-29) Omega 3 fatty acids increase the chemo-sensitivity of B-CLL-derived cell lines EHEB and MEC-2 and of B-PLL-derived cell line JVM-2 to anti-cancer drugs doxorubicin, vincristine and fludarabine.Johannes F Fahrmann et al.Lipids in health and disease, 12, 36-36 (2013-03-19) Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia.Maurizio Miano et al.Journal of pediatric hematology/oncology, 36(3), e145-e148 (2013-04-17) Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.Peter Martin et al.Cancer, 119(23), 4129-4136 (2013-09-06) Feasibility of the fludarabine busulfan 3 days and ATG 2 days reduced toxicity conditioning in 51 allogeneic hematopoietic stem cell transplantation: a single-center experience.S P Chantepie et al.Leukemia research, 38(5), 569-574 (2014-03-25) The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.I Hubeek et al.British journal of cancer, 93(12), 1388-1394 (2005-12-08) Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced-intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo-SCT).Amandine Le Bourgeois et al.European journal of haematology, 90(3), 177-186 (2013-01-11) Bendamustine plus alemtuzumab is safe and feasible treatment for fludarabine refractory chronic lymphocytic leukaemia (CLL).Brian T Hill et al.British journal of haematology, 164(2), 297-299 (2013-10-18) In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.Yoshinobu Kanda et al.American journal of hematology, 88(4), 294-300 (2013-03-02) Early-onset therapy-related myelodysplastic syndrome originating from prolonged myelosuppression after fludarabine-based therapy.Sho Yamazaki et al.Internal medicine (Tokyo, Japan), 51(24), 3427-3430 (2012-12-22) Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism.P Huang et al.Molecular pharmacology, 39(4), 449-455 (1991-04-01) Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation.Yue Yang et al.Experimental and molecular pathology, 95(1), 7-17 (2013-04-10) [Fatal zygomycosis caused by Mucor indicus after haplo-identical stem cell transplantation].Satoko Koteda et al.[Rinsho ketsueki] The Japanese journal of clinical hematology, 54(3), 311-315 (2013-05-17) Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation.Martine F Raphael et al.The European respiratory journal, 41(2), 479-483 (2013-02-02) Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.Budiman Kharma et al.International journal of cancer, 133(9), 2234-2244 (2013-04-19) Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.Adam L Palazzo et al.PloS one, 6(10), e24592-e24592 (2011-10-22) BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD.Issa F Khouri et al.Blood, 124(14), 2306-2312 (2014-08-26) Transposon Mutagenesis Reveals Fludarabine Resistance Mechanisms in Chronic Lymphocytic Leukemia.Tatjana Pandzic et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 22(24), 6217-6227 (2016-03-10) High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation.J R Long-Boyle et al.Bone marrow transplantation, 46(1), 20-26 (2010-04-13) Treatment practice in the elderly patient with chronic lymphocytic leukemia-analysis of the combined SEER and Medicare database.Sacha Satram-Hoang et al.Annals of hematology, 93(8), 1335-1344 (2014-03-19) Fludarabine: a review of the clear benefits and potential harms.Joshua Lukenbill et al.Leukemia research, 37(9), 986-994 (2013-06-22) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).Zhichao Liu et al.PLoS computational biology, 7(12), e1002310-e1002310 (2011-12-24)

备注